Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
El Amrani M, van den Broek MP, Göbel C, van Maarseveen EM. El Amrani M, et al. Among authors: van den broek mp, van maarseveen em. J Chromatogr A. 2016 Jul 8;1454:42-8. doi: 10.1016/j.chroma.2016.05.070. Epub 2016 May 22. J Chromatogr A. 2016. PMID: 27264745
Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Kromdijk W, Rosing H, van den Broek MP, Beijnen JH, Huitema AD. Kromdijk W, et al. Among authors: van den broek mp. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 1;891-892:57-63. doi: 10.1016/j.jchromb.2012.02.026. Epub 2012 Feb 23. J Chromatogr B Analyt Technol Biomed Life Sci. 2012. PMID: 22418071
First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
van der Schaft J, van Schaik RH, van Zuilen AD, Hijnen DJ, Berg MT, van den Broek MP, Bruijnzeel-Koomen CA, de Bruin-Weller MS. van der Schaft J, et al. Among authors: van den broek mp, van zuilen ad, van schaik rh. J Dermatol Sci. 2016 Jan;81(1):66-8. doi: 10.1016/j.jdermsci.2015.10.013. Epub 2015 Oct 28. J Dermatol Sci. 2016. PMID: 26547110 No abstract available.
51 results